long-term outlook intact upsid limit
downgrad neutral pt
view zimmer turnaround stori began earnest new ceo drove
mark shift compani cultur new head ir vastli improv
commun street despit favor shift messag
strategi share nonetheless set end year ep estim
continu move lower mostli one-tim item top-lin
recoveri happen slower-than-expect pace compani top line
like remain depress throughout work stabil suppli get
rep back track bottom-lin weigh elev
remedi expens continu invest back busi unfortun
mean oper margin look much like
push compani financi recoveri firmli think zimmer
long-term outlook remain track also see limit upsid current street
expect near-term look revisit stori move closer
look like anoth transit year downgrad
share lower dec price target ep
clear believ zimmer biomet made notabl progress cours
new manag led impress shift beat-and-rais cultur
three consecut quarter out-performance far led share
peak septemb one-tim item fx bone cement
result lower top- bottom-lin outlook share set end
year given zimmer statu recoveri stori surpris
see share sell much near/mid-term estim move lower
rather higher even recent beat-and-rais quarter investor still wari
potenti delay compani path back normal oper
share enter year depress valuat ep vs peer
dont expect multipl expans estim steadili move
higher there clearli work need done compani
sustain grow market level on-going suppli remedi track
like still weigh top-lin growth gradual improv sale
rep product gain confid compani suppli situat work
reconnect surgeon limit benefit new product launch
begin full commerci launch supplier disrupt within
bone cement busi headwind
page analyst certif import disclosur
 morgan seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report singl
factor make invest decis
told get us estim sale slightli street
growth report organ repres
step organ growth model full year strongest
quarter actual easi comp organ ex-sel day
growth follow quarter dive deeper
product segment level model knee growth take step organ
vs organ compani benefit addit persona
line modest benefit rosa follow full launch detail around
system remain limit expect zimmer favor gradual roll-out
kol compani work stabil base busi compet
stryker meaning head-start mako side large-joint ortho hip
growth remain rel healthi organ vs organ
given easier competit dynam elsewher expect recoveri set take
longer vs buildout benefit salesforc special
off-set difficult suppli recoveri final expect dental vs
spine vs stabil somewhat remain lower-growth piec
portfolio
coupl notabl headwind
significantli limit margin improv gross margin line
compani manufactur remain ineffici increas outsourc
manual inspect temporari labor continu weigh margin good
amount spend begin fall especi warn
letter resolv could happen time cost alreadi
capit inventori compani work cours
gm hedg serv modest off-set model gross margin
year gm come
oper spend sg remain elev zimmer continu invest
manufactur improv special salesforc model point
toward spend sale flat compani
toward attract
opportun sale coupl fx model cash ep come
line street
pipelin
top bottom line weigh on-going suppli remedi
upsid estim unlik downgrad zimmer neutral
lower pt clear long-term thesi compani
remain intact beyond bullish compani abil return market
growth organ initi alon upsid tabl
becom bigger piec puzzl possibl dental sale acquisit
diversifi away lower-growth ortho margin natur improv well
zimmer put warsaw issu behind ep growth tick
hsd rang think profil warrant better multipl today discount
peer dont see compani close valuat gap meaning
near-term estim begin sustain move higher look revisit
stori get closer present downgrad share neutral
lower pt price-to-earnings discount peer vs
reflect compani lower end-market growth rate vs on-going
invest thesi valuat risk
view zimmer turnaround stori began earnest new ceo
drove mark shift compani cultur new head ir vastli improv
commun street despit favor shift messag
strategi share nonetheless set end year ep estim
continu move lower mostli one-tim item top-
line recoveri happen slower-than-expect pace compani top
line like remain depress throughout work stabil suppli
get rep back track bottom-lin weigh elev
remedi expens continu invest back busi
unfortun mean oper margin look much like
push compani financi recoveri firmli
think zimmer long-term outlook remain track also see limit upsid
current street expect near-term look revisit stori
move closer look like anoth transit year
downgrad share neutral
look revisit stori get closer present
downgrad share neutral lower pt price-to-earnings discount
peer vs reflect compani lower end-market growth rate
vs on-going recoveri
risk rate price
upsid risk includ quicker suppli recoveri previous expect
favor uptak new product launch better expect expens
manag value-ad respect
potenti divestitur acquisit
downsid risk includ long tail merger dis-synergi owe signific
product custom overlap manag abil address recent qualiti
issu potenti increment cost address issu share
loss knee post launch stryker mako total knee system
summari financi
cash equival
flow oper activ
o/w chang work capit
flow invest activ
sale
flow financ activ
net chang cash
adj free cash flow firm
compani report morgan estim
note million except per-shar data fiscal year end dec o/w
analyst certif research analyst denot ac cover report certifi multipl research
analyst primarili respons report research analyst denot ac cover within document
individu certifi respect secur issuer research analyst cover research view
express report accur reflect person view subject secur issuer part
research analyst compens directli indirectli relat specif recommend view
express research analyst report korea-bas research analyst list front cover also certifi per
kofia requir analysi made good faith view reflect opinion without undu influenc
